Kohei Takano
Scientist, Discovery Research Daiichi Sankyo
Kohei Takano is a scientist at Daiichi Sankyo, Discovery Research Laboratories I, engaged in oncology drug discovery with a focus on ADCs. His work centers on the design, execution, and interpretation of nonclinical pharmacological research. He is the first author of a peer reviewed publication reporting the nonclinical data of DS 3939a in Molecular Cancer Therapeutics, providing the scientific basis for its clinical development.
Seminars
Wednesday 14th October 2026
Highlighting Preclinical Development of DS-3939a, a DXd-ADC Targeting TA-MUC1
2:00 pm
- Overviewing the DXd-ADC technology platform and pipeline
- Exploring target biology and rationale for targeting TA-MUC1 with an ADC in solid tumors
- Highlighting the preclinical pharmacology profile of DS-3939a, a TA-MUC1 directed DXd-ADC
